Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.

Infection and Immunity
J B DaleM R Wessels

Abstract

The major virulence determinant of group A streptococci is the ability to resist opsonization and phagocytic ingestion. The present studies were performed to compare the mechanisms of resistance to opsonization of type 18 and type 24 streptococci and to determine the relative roles of M protein-fibrinogen interaction and the hyaluronate capsule in preventing phagocytic ingestion and killing. By use of parent strains and acapsular transposon mutants in the presence and absence of fibrinogen, we show that type 18 and type 24 streptococci rely on somewhat different mechanisms for resistance to opsonization. Type 24 streptococci bound fibrinogen avidly to their surfaces, and encapsulated organisms were completely resistant to opsonization only in the presence of fibrinogen. In contrast, type 18 streptococci bound 10-fold less fibrinogen than type 24 streptococci and were fully resistant to phagocytosis only when they expressed capsule. The general structural characteristics of the amino-terminal halves of type 18 and type 24 M proteins differed in that type 18 M protein contained only one complete B repeat, whereas type 24 M protein contained five complete B repeats, a structural difference which could potentially be related to the...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Apr 1, 1976·The Journal of Experimental Medicine·E H Beachey, I Ofek
Dec 1, 1992·Infection and Immunity·R D HorstmannV A Fischetti
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M R WesselsT J DiCesare
Jun 1, 1985·The Journal of Experimental Medicine·V A FischettiJ R Scott
Jul 1, 1989·Clinical Microbiology Reviews·V A Fischetti
May 25, 1988·Nucleic Acids Research·E Haanes-FritzP Cleary
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R D HorstmannV A Fischetti
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G N PhillipsV A Fischetti
Apr 1, 1982·The Journal of Clinical Investigation·E Whitnack, E H Beachey
Jan 1, 1995·Infection and Immunity·V A FischettiV Pancholi
Mar 1, 1995·The Journal of Infectious Diseases·R E CampoA L Bisno
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·M R Wessels, M S Bronze
Mar 1, 1960·The Journal of Experimental Medicine·J G HIRSCH, A B CHURCH
Mar 1, 1944·The Journal of Experimental Medicine·E H Kass, C V Seastone

❮ Previous
Next ❯

Citations

Jun 22, 1999·Immunologic Research·E R Brandt, M F Good
Feb 26, 2000·Infection and Immunity·G L DarmstadtC E Rubens
Apr 9, 2001·Infection and Immunity·D G McLellanJ B Dale
Dec 1, 2001·Nature Medicine·M M Frank
Oct 7, 2004·The Journal of Biological Chemistry·Johnson AgniswamyPeter D Sun
Nov 14, 2006·Journal of Bacteriology·Jeffrey B LockeJohn T Buchanan
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ioannis GryllosMichael R Wessels
Sep 17, 2011·Nature Reviews. Microbiology·Jason N ColeMark J Walker
Jan 9, 2013·Infection and Immunity·Yoann Le BretonKevin S McIver
Oct 1, 2014·The Journal of Biological Chemistry·Anna HenninghamJason N Cole
Jun 12, 1998·Pediatric Annals·J B Dale
Oct 18, 2000·The Journal of Clinical Investigation·C CywesM R Wessels
May 4, 1999·The Journal of Clinical Investigation·J B DaleD L Hasty
May 8, 2003·The British Journal of Surgery·M M P J ReijnenH van Goor
Oct 16, 2002·Infection and Immunity·Vinod PandiripallyDavid Cue
Mar 7, 2012·Applied Microbiology and Biotechnology·Paul L DeAngelis
Apr 5, 2013·Biological Reviews of the Cambridge Philosophical Society·Eyal KamhiRobert J Linhardt
Apr 4, 2014·Clinical Microbiology Reviews·Mark J WalkerVictor Nizet
Jul 26, 2013·Therapeutic Delivery·Alicia Sawdon, Ching-An Peng
Jul 10, 2018·Journal of the Pediatric Infectious Diseases Society·Stanford T Shulman, James B Dale
Aug 15, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Roberta CretiMonica Imperi
Sep 3, 1998·The Journal of Biological Chemistry·V NickelP Prehm
Mar 24, 2004·Nature Reviews. Microbiology·Timothy J Mitchell
Jul 31, 2007·Future Microbiology·Laura A Kwinn, Victor Nizet
Aug 31, 2006·The Pediatric Infectious Disease Journal·Thomas B MartinsHarry R Hill
Feb 12, 2015·FEMS Microbiology Reviews·Anna HenninghamJason N Cole
Dec 28, 1999·British Journal of Obstetrics and Gynaecology·A S KentJ L Beynon
Oct 30, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E A AhmedJ B Dale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
M R WesselsT J DiCesare
Zentralblatt Für Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie Und Parasitologie
S Tylewska, W Hryniewicz
Proceedings of the National Academy of Sciences of the United States of America
M R Wessels, M S Bronze
© 2021 Meta ULC. All rights reserved